David Douin
Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oxygen Inhalation Therapy | 5 | 2026 | 182 | 3.510 |
Why?
| | Wounds and Injuries | 15 | 2026 | 957 | 3.250 |
Why?
| | Oxygen | 8 | 2026 | 995 | 2.580 |
Why?
| | Critical Illness | 9 | 2025 | 892 | 1.680 |
Why?
| | Resuscitation | 3 | 2024 | 302 | 1.470 |
Why?
| | Intubation, Intratracheal | 5 | 2025 | 320 | 0.910 |
Why?
| | Hyperoxia | 3 | 2023 | 99 | 0.900 |
Why?
| | Positive-Pressure Respiration | 2 | 2025 | 112 | 0.870 |
Why?
| | Hypoxia | 5 | 2026 | 1199 | 0.840 |
Why?
| | Hemostatics | 1 | 2023 | 61 | 0.770 |
Why?
| | Hospitalization | 16 | 2022 | 2434 | 0.720 |
Why?
| | Thrombophilia | 1 | 2022 | 88 | 0.700 |
Why?
| | Anesthetics, Inhalation | 1 | 2021 | 52 | 0.660 |
Why?
| | Propofol | 1 | 2021 | 85 | 0.640 |
Why?
| | Airway Management | 3 | 2025 | 79 | 0.630 |
Why?
| | Burns | 1 | 2025 | 377 | 0.630 |
Why?
| | Esophageal Fistula | 1 | 2020 | 21 | 0.630 |
Why?
| | Brain Injuries, Traumatic | 2 | 2023 | 441 | 0.620 |
Why?
| | Tissue Plasminogen Activator | 1 | 2021 | 244 | 0.610 |
Why?
| | Respiration, Artificial | 8 | 2023 | 708 | 0.590 |
Why?
| | Blood Transfusion | 4 | 2025 | 405 | 0.570 |
Why?
| | Brain Injuries | 1 | 2023 | 508 | 0.520 |
Why?
| | Anesthesia | 1 | 2021 | 258 | 0.520 |
Why?
| | Hemorrhage | 4 | 2025 | 809 | 0.500 |
Why?
| | Humans | 55 | 2026 | 144957 | 0.490 |
Why?
| | Adult | 32 | 2026 | 40506 | 0.480 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2020 | 383 | 0.450 |
Why?
| | Hospital Mortality | 6 | 2025 | 1031 | 0.410 |
Why?
| | Fibrinogen | 2 | 2024 | 177 | 0.380 |
Why?
| | Oximetry | 3 | 2026 | 126 | 0.310 |
Why?
| | Anesthesiology | 2 | 2022 | 175 | 0.300 |
Why?
| | Middle Aged | 21 | 2025 | 35928 | 0.290 |
Why?
| | Neoplasms | 2 | 2021 | 2884 | 0.280 |
Why?
| | Aged | 18 | 2025 | 25947 | 0.280 |
Why?
| | Lung | 1 | 2021 | 4109 | 0.280 |
Why?
| | Influenza Vaccines | 2 | 2022 | 529 | 0.270 |
Why?
| | Multicenter Studies as Topic | 2 | 2026 | 405 | 0.250 |
Why?
| | Influenza, Human | 2 | 2022 | 617 | 0.240 |
Why?
| | Male | 23 | 2025 | 72406 | 0.240 |
Why?
| | Etomidate | 1 | 2025 | 18 | 0.230 |
Why?
| | Trauma Centers | 2 | 2025 | 462 | 0.230 |
Why?
| | Treatment Outcome | 5 | 2025 | 11695 | 0.230 |
Why?
| | Retrospective Studies | 8 | 2025 | 17101 | 0.220 |
Why?
| | Anesthetics, Intravenous | 2 | 2025 | 69 | 0.220 |
Why?
| | Burn Units | 1 | 2025 | 48 | 0.220 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1524 | 0.220 |
Why?
| | Coated Materials, Biocompatible | 1 | 2025 | 65 | 0.220 |
Why?
| | Cellular Microenvironment | 1 | 2025 | 94 | 0.220 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2025 | 57 | 0.220 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2025 | 72 | 0.220 |
Why?
| | Wound Infection | 1 | 2025 | 57 | 0.210 |
Why?
| | Vaccines, Synthetic | 5 | 2022 | 138 | 0.210 |
Why?
| | Transfusion Reaction | 1 | 2025 | 63 | 0.210 |
Why?
| | Emergency Service, Hospital | 3 | 2025 | 2313 | 0.210 |
Why?
| | Ketamine | 1 | 2025 | 133 | 0.210 |
Why?
| | Blood Coagulation Factors | 1 | 2024 | 55 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 129 | 0.210 |
Why?
| | Abdomen | 1 | 2025 | 141 | 0.210 |
Why?
| | Blood Component Transfusion | 1 | 2025 | 103 | 0.210 |
Why?
| | Intensive Care Units | 3 | 2025 | 916 | 0.200 |
Why?
| | Data Interpretation, Statistical | 1 | 2026 | 372 | 0.200 |
Why?
| | Pseudomonas Infections | 1 | 2025 | 221 | 0.200 |
Why?
| | United States | 15 | 2025 | 15988 | 0.200 |
Why?
| | Female | 22 | 2025 | 78376 | 0.200 |
Why?
| | Quality Improvement | 4 | 2025 | 1291 | 0.190 |
Why?
| | Immunocompromised Host | 2 | 2022 | 201 | 0.190 |
Why?
| | Prospective Studies | 4 | 2025 | 7997 | 0.190 |
Why?
| | Cross-Over Studies | 1 | 2025 | 601 | 0.190 |
Why?
| | Anti-Infective Agents | 1 | 2025 | 242 | 0.190 |
Why?
| | Perioperative Care | 1 | 2025 | 231 | 0.180 |
Why?
| | Anesthesia, Cardiac Procedures | 1 | 2022 | 27 | 0.180 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2026 | 1721 | 0.170 |
Why?
| | Immunization, Secondary | 1 | 2022 | 91 | 0.170 |
Why?
| | Treatment Failure | 1 | 2022 | 365 | 0.170 |
Why?
| | Anesthesia, Intravenous | 1 | 2021 | 24 | 0.170 |
Why?
| | Adrenal Cortex Hormones | 2 | 2021 | 479 | 0.170 |
Why?
| | Cell Movement | 1 | 2025 | 965 | 0.170 |
Why?
| | Aftercare | 1 | 2022 | 224 | 0.160 |
Why?
| | Postoperative Period | 1 | 2021 | 354 | 0.160 |
Why?
| | Antibodies, Neutralizing | 1 | 2022 | 341 | 0.150 |
Why?
| | Neutrophils | 1 | 2025 | 1134 | 0.150 |
Why?
| | Adolescent | 12 | 2025 | 22453 | 0.150 |
Why?
| | Oxygen Consumption | 1 | 2023 | 724 | 0.150 |
Why?
| | Research Design | 1 | 2026 | 1137 | 0.150 |
Why?
| | Organ Transplantation | 1 | 2022 | 248 | 0.150 |
Why?
| | Outpatients | 1 | 2022 | 443 | 0.140 |
Why?
| | Esophagectomy | 1 | 2020 | 135 | 0.140 |
Why?
| | Acute Lung Injury | 1 | 2022 | 303 | 0.140 |
Why?
| | Vaccination | 3 | 2021 | 1423 | 0.140 |
Why?
| | Sepsis | 1 | 2025 | 641 | 0.140 |
Why?
| | Cohort Studies | 4 | 2021 | 5965 | 0.140 |
Why?
| | Insurance, Health | 1 | 2020 | 303 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Respiratory Insufficiency | 1 | 2021 | 326 | 0.130 |
Why?
| | Burnout, Professional | 1 | 2023 | 484 | 0.120 |
Why?
| | Patient Discharge | 1 | 2022 | 983 | 0.120 |
Why?
| | Registries | 1 | 2024 | 2385 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1915 | 0.110 |
Why?
| | RNA, Messenger | 4 | 2023 | 2832 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2021 | 988 | 0.110 |
Why?
| | Physicians | 1 | 2022 | 940 | 0.100 |
Why?
| | Vaccines, Combined | 2 | 2022 | 49 | 0.090 |
Why?
| | Injury Severity Score | 2 | 2025 | 600 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2025 | 2920 | 0.090 |
Why?
| | Anesthesiologists | 2 | 2023 | 67 | 0.090 |
Why?
| | Young Adult | 6 | 2025 | 14126 | 0.090 |
Why?
| | Case-Control Studies | 3 | 2022 | 3608 | 0.080 |
Why?
| | Severity of Illness Index | 3 | 2022 | 2925 | 0.080 |
Why?
| | Child, Preschool | 4 | 2025 | 11799 | 0.080 |
Why?
| | Obesity | 1 | 2022 | 3082 | 0.070 |
Why?
| | Pandemics | 3 | 2023 | 1695 | 0.070 |
Why?
| | Mortality | 2 | 2021 | 376 | 0.070 |
Why?
| | Critical Care | 2 | 2023 | 697 | 0.060 |
Why?
| | Infant | 3 | 2025 | 10039 | 0.060 |
Why?
| | RNA | 2 | 2023 | 940 | 0.060 |
Why?
| | Anesthetics, Dissociative | 1 | 2025 | 46 | 0.060 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2025 | 113 | 0.060 |
Why?
| | Comorbidity | 2 | 2020 | 1660 | 0.060 |
Why?
| | Child | 4 | 2025 | 22657 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 2 | 2024 | 1358 | 0.050 |
Why?
| | Freeze Drying | 1 | 2024 | 82 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2025 | 310 | 0.050 |
Why?
| | Elective Surgical Procedures | 1 | 2025 | 201 | 0.050 |
Why?
| | Pseudomonas aeruginosa | 1 | 2025 | 356 | 0.050 |
Why?
| | Biofilms | 1 | 2025 | 278 | 0.050 |
Why?
| | Tracheostomy | 1 | 2024 | 142 | 0.050 |
Why?
| | Blood Coagulation Disorders | 1 | 2024 | 189 | 0.050 |
Why?
| | Immunocompetence | 1 | 2022 | 47 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2023 | 5872 | 0.040 |
Why?
| | Syndrome | 1 | 2022 | 380 | 0.040 |
Why?
| | Heart Arrest | 1 | 2025 | 407 | 0.040 |
Why?
| | Viral Load | 1 | 2023 | 526 | 0.040 |
Why?
| | Prone Position | 1 | 2021 | 24 | 0.040 |
Why?
| | Receptors, Interleukin-6 | 1 | 2021 | 47 | 0.040 |
Why?
| | Immunization Schedule | 1 | 2022 | 187 | 0.040 |
Why?
| | Transplant Recipients | 1 | 2022 | 180 | 0.040 |
Why?
| | Organ Dysfunction Scores | 1 | 2021 | 53 | 0.040 |
Why?
| | Early Medical Intervention | 1 | 2021 | 61 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2021 | 134 | 0.040 |
Why?
| | Patient Positioning | 1 | 2021 | 70 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 53 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 6053 | 0.040 |
Why?
| | Vaccination Coverage | 1 | 2021 | 103 | 0.040 |
Why?
| | Time Factors | 2 | 2021 | 7183 | 0.040 |
Why?
| | Managed Care Programs | 1 | 2020 | 140 | 0.040 |
Why?
| | RNA, Viral | 1 | 2023 | 688 | 0.040 |
Why?
| | Databases, Factual | 1 | 2025 | 1486 | 0.040 |
Why?
| | Risk Factors | 2 | 2025 | 10792 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2020 | 245 | 0.030 |
Why?
| | Linear Models | 1 | 2020 | 854 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1077 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2021 | 265 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1325 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2022 | 1054 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2021 | 589 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1540 | 0.030 |
Why?
| | Medicaid | 1 | 2020 | 462 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1813 | 0.030 |
Why?
| | Anticoagulants | 1 | 2021 | 724 | 0.030 |
Why?
| | Pilot Projects | 1 | 2021 | 1890 | 0.030 |
Why?
| | Logistic Models | 1 | 2020 | 2119 | 0.030 |
Why?
| | Medicare | 1 | 2020 | 887 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2852 | 0.030 |
Why?
| | Age Factors | 1 | 2020 | 3335 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2024 | 8279 | 0.020 |
Why?
| | Risk Assessment | 1 | 2021 | 3676 | 0.020 |
Why?
|
|
Douin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|